Search
for
Sort by
Research 30 of 860
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Lichen myxedematosus in a patient with hepatocellular carcinoma
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels
- Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Phytochemical and nanoparticle-based therapeutic potential of Sphaeranthus indicus against hepatocellular carcinoma via cryptomeridiol targeting
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- Transarterial chemoembolization (TACE) combined with donafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A real-world clinical study.
- Author response: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma
- Decision letter: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
- S3507 GI Bleed Leading to Discovery of Hereditary Hemochromatosis
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Sorafenib-induced Facial Acneiform Eruption
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Homeostasis and Cancer Symptom in Elemental Concentration Profiles of Hair Observed by Fluorescent X-ray Analysis with Synchrotron Radiation
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- Bioguided Fraction and Isolation of the Antitumor Components from<i>Phyllanthus niruri</i>L.
- Sorafenib-induced eruption resembling pityriasis rubra pilaris
- Drug-induced postinfantile giant cell hepatitis
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- An in vitro study on the effects of homeopathic Radium bromatum (9CH, 12CH, and 30CH potencies) on cancer cells